In vitro activity of the β-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum

Experimental Parasitology

Volumn 106, Issue 3-4, 2004, Pages 67-74

  Di Giorgio, C ^a   Delmas, F ^a   Ollivier, E ^a   Elias, R ^a   Balansard, G ^a   Timon David, P ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; BETA CARBOLINE; HARMALINE; HARMAN; HARMINE; PROTEIN KINASE C;

AMASTIGOTE; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; DNA METABOLISM; DRUG ACTIVITY; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; LEISHMANIA DONOVANI; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE;

ANIMALS; ANTIPROTOZOAL AGENTS; HARMALINE; HARMINE; HUMANS; LEISHMANIA INFANTUM; MACROPHAGES; MEMBRANE POTENTIALS; MONOCYTES; PROTEIN KINASE C;

LEISHMANIA INFANTUM;

EID: 2542434992     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exppara.2004.04.002     Document Type: Article

References (40)

1. Aassila H., Bourguet-Kondracki M.L., Rifai S., Fassouane A., Guyot M. Identification of harman as the antibiotic compound produced by a tunicate-associated bacterium. Marine Biotechnol. (NY). 5(2):2003;163-166
2. Azas N., Di Giorgio C., Delmas F., Gasquet M., Timon-David P. Assessment of amphotericin B susceptibility in Leishmania infantum promastigotes by flow cytometric membrane potential assay. Cytometry. 28:1997;165-169
3. Bennati E. Quantitative determination of harmane and harmine in the extract of Passiflora incarnata. Boll. Chim. Farm. 110:1971;664-669
4. Bente M., Harder S., Wiesgigl M., Heukeshoven J., Gelhaus C., Krause E., Clos J., Bruchhaus I. Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani. Proteomics. 3:2003;1811-1829
5. Bourke C.A., Stevens G.R., Carrigan M.J. Locomotor effects in sheep of alkaloids identified in Australian Tribulus terrestris. Aust. Vet. J. 69:1992;163-165
6. Boeira J.M., da Silva J., Erdtmann B., Henriques J.A. Genotoxic effects of the alkaloids harman and harmine assessed by comet assay and chromosome aberration test in mammalian cells in vitro. Pharmacol. Toxicol. 89:2001;287-294
7. Bogdan C., Gessner A., Solbach W., Rollinghoff M. Invasion, control and persistence of Leishmania parasites. Curr. Opin. Immunol. 8:1996;517-525
8. Crissman H.A., Darzynkiewicz Z., Steinkamp J.A., Tobey R.A. Simultaneous fluorescent labelling of DNA, RNA, and protein. Methods Cell Biol. 33:1990;305-314
9. Croft S.L., Yardley V. Chemotherapy of leishmaniasis. Curr. Pharm. 8:2002;319-342
10. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:1988;2407-2412
11. Evans A.T., Croft S.L. Antileishmanial activity of harmaline and other tryptamine derivatives. Phytother. Res. 1:1987;25-27
12. Freiburghaus F., Kamisky R., Nkunya M.H., Brun R. Evaluation of African medicinal plants for their in vitro trypanocidal activity. J. Ethnopharmacol. 55:1996;1-11
13. Funayama Y., Nishio K., Wakabayashi K., Nagao M., Shimoi K., Ohira T., Hasegawa S., Saijo N. Effects of beta- and gamma-carboline derivatives of DNA topoisomerase activities. Mutat. Res. 349:1996;183-191
14. Glover V., Liebowitz J., Armando I., Sandler M. Beta-carbolines as selective monoamine oxidase inhibitors: in vivo implications. J. Neural Transm. 54:1982;209-218
15. Greenspan P., Mayer E.P., Fowler S.D. Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100:1985;965-973
16. Grimaldi R., Tesh G.R., McMahon-Pratt M. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am. J. Trop. Med. Hyg. 41:1989;687
17. Gyan Y., Louis E.D., Zheng W. Toxicokinetics of tremorogenic natural products, harmane and harmine in male Sprague-Dawley rats. J. Toxicol. Environ. Health. 64:2001;645-660
18. Hammarton T.C., Mottram J.C., Doerig C., Heinrich M., Gibbons S. Ethnopharmacology in drug discovery: an analysis of its role and potential contribution. Pharmacy Pharmacol. 53:2001;425-432
19. Hermoso T., Jaffe C.L. Phosphorylation of proteins in virulent promastigotes from Leishmania major. Biol. Res. 26(1-2):1993;267-271
20. Herraiz T. Tetrahydro-beta-carboline-3-carboxylic acid compounds in fish and meat: possible precursors of co-mutagenic beta-carbolines norharman and harman in cooked foods. Food Addit. Contamin. 178:2000;59-66
21. Herwalt B.L. Leishmaniasis. Lancet. 354:1999;1191-1199
22. Ishida J., Wang H.K., Masayoshi O., Cosentino C.L., Hu C.Q., Lee K.H. Anti-aids agents 46. Anti-HIV activity of harman, an anti-HIV principle from symplocos setchuensis and its derivatives. J. Nat. Prod. 64:2001;958-960
23. Jaspers M.W., Bashir A.K., Zwaving J.H., Malingre T.M. Investigation of Grewia bicolor Juss. J. Ethnopharmacol. 17:1986;205-211
24. Lagunin A., Stepanchikova A., Filimonov D., Poroikov V. PASS: prediction of activity spectra for biologically active substances. Bioinformatics. 16:2000;747-748
25. Murray H.W. Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches. Int. J. Infect. Dis. 4:2000;158-177
26. O'Connor J.E., Kimler B.F., Morgan M.C., Tempas K.J. A flow cytometric assay for intracellular nonprotein thiols using mercury orange. Cytometry. 9:1988;529-532
27. Oda Y., Nakamura S., Oki I. Harman and norharman induce SOS responses and frameshift mutations in bacteria. Mutat. Res. 208:1988;39-44
28. Ogunkolade B.W., Colomb-Valet I., Monjour J., Rhodes-Feuillette A., Abita J.P., Frommel D. Interactions between the human monocytic leukaemia THP1 cell line and Old and New World species of Leishmania. Acta Trop. 47:1990;171-176
29. Picada J.N., da Silva K.V., Erdtmann B., Henriques A.T., Henriques J.A. Genotoxic effects of structurally related betacarboline alkaloids. Mutat. Res. 379:1997;135-149
30. Poroikov V.V., Filimonov D., Borodina Y., Lagunin A., Kos A. Robustness of biological activity spectra predicting by computer program pass for non-congeneric sets of chemical compounds. J. Chem. Informat. Comput. Sci. 40:2000;1349-1355
31. Rivas P., Cassels B.K., Morello A., Repetto Y. Effects of some beta-carboline alkaloids on intact Trypanosoma cruzi epimastigotes. Comp. Biochem.: Physiol., Pharmacol., Toxicol., Endocrinol. 122:1999;27-31
32. Shi C.C., Chen S.Y., Wang G.J., Liao J.F., Chen C.F. Vasorelaxant effect of harman. Eur. J. Pharmacol. 390:2000;319-325
33. Shi C.C., Liao J.F., Chen C.F. Spasmolytic effects of three harman alkaloids on guinea-pig isolated trachea. Pharmacol. Toxicol. 89:2001;259-264
34. Shapiro H.M. Microbial analysis at the single-cell level: tasks and techniques. J. Microbiol. Methods. 42:2000;3-16
35. Sibley D.L., Norma A. Cell invasion by un-palatable parasites. Traffic. 1:2000;100-106
36. Tekto I.V., Tanchuk Y., Villa A. Prediction of n-octanol/water partition coefficients from PHYSPROP database using artificial neural networks and E-state indices. J. Chem. Informat. Comput. Sci. 41:2001;1407-1421
37. Totsuka Y., Ushiyama H., Ishihara J., Rashmi S., Sumio S., Sugimura T., Wakabayashi K. Quantification of the co-mutagenic β-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods. Cancer Lett. 143:1999;139-143
38. Tsuchiya H., Sato M., Watanabe I. Antiplatelet activity of soy sauce as functional seasoning. J. Agri. Food Chem. 47:1999;4167-4174
39. Vannier-Santos M.A., Martiny A., Meyer-Fernandes J.R., de Souza W. Leishmanial protein kinase C modulates host cell infection via secreted acid phosphatase. Eur. J. Cell Biol. 67(2):1995;112-119
40. Wiese M. A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host. EMBO J. 17(9):1998;2619-2628